Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach.

PROMs clinical outcome assessments dysferlinopathy limb girdle muscular dystrophy quality of life

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 03 12 2021
accepted: 31 01 2022
entrez: 1 4 2022
pubmed: 2 4 2022
medline: 2 4 2022
Statut: epublish

Résumé

Dysferlinopathy is a muscular dystrophy with a highly variable functional disease progression in which the relationship of function to some patient reported outcome measures (PROMs) has not been previously reported. This analysis aims to identify the suitability of PROMs and their association with motor performance.Two-hundred and four patients with dysferlinopathy were identified in the Jain Foundation's Clinical Outcome Study in Dysferlinopathy from 14 sites in 8 countries. All patients completed the following PROMs: Individualized Neuromuscular Quality of Life Questionnaire (INQoL), International Physical Activity Questionnaire (IPAQ), and activity limitations for patients with upper and/or lower limb impairments (ACTIVLIMs). In addition, nonambulant patients completed the Egen Klassifikation Scale (EK). Assessments were conducted annually at baseline, years 1, 2, 3, and 4. Data were also collected on the North Star Assessment for Limb Girdle Type Muscular Dystrophies (NSAD) and Performance of Upper Limb (PUL) at these time points from year 2. Data were analyzed using descriptive statistics and Rasch analysis was conducted on ACTIVLIM, EK, INQoL. For associations, graphs (NSAD with ACTIVLIM, IPAQ and INQoL and EK with PUL) were generated from generalized estimating equations (GEE). The ACTIVLIM appeared robust psychometrically and was strongly associated with the NSAD total score (Pseudo

Identifiants

pubmed: 35359643
doi: 10.3389/fneur.2022.828525
pmc: PMC8961025
doi:

Types de publication

Journal Article

Langues

eng

Pagination

828525

Informations de copyright

Copyright © 2022 Mayhew, James, Moore, Sutherland, Jacobs, Feng, Lowes, Alfano, Muni Lofra, Rufibach, Rose, Duong, Bello, Pedrosa-Hernández, Holsten, Sakamoto, Canal, Sánchez-Aguilera Práxedes, Thiele, Siener, Vandevelde, DeWolf, Maron, Gordish-Dressman, Hilsden, Guglieri, Hogrel, Blamire, Carlier, Spuler, Day, Jones, Bharucha-Goebel, Salort-Campana, Pestronk, Walter, Paradas, Stojkovic, Mori-Yoshimura, Bravver, Díaz-Manera, Pegoraro, Mendell and Straub.

Déclaration de conflit d'intérêts

MJ receives fee support for PhD studies from the Jain Foundation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Acta Myol. 2011 Oct;30(2):127-32
pubmed: 22106716
Dev Med Child Neurol. 2008 Jun;50(6):408-9
pubmed: 18489458
Hum Mutat. 2005 Aug;26(2):165
pubmed: 16010686
Neuromuscul Disord. 2016 Mar;26(3):211-20
pubmed: 26826887
Neuromuscul Disord. 2008 Apr;18(4):288-90
pubmed: 18396043
Disabil Rehabil. 2021 Nov 15;:1-9
pubmed: 34780317
Ann Neurol. 2021 May;89(5):967-978
pubmed: 33576057
Neuromuscul Disord. 2012 Dec;22(12):1069-74
pubmed: 23127961
Neurology. 2007 Mar 27;68(13):1051-7
pubmed: 17389311
Muscle Nerve. 2016 Nov;54(5):821-835
pubmed: 27501525
J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):946-53
pubmed: 19528035
Dev Med Child Neurol. 2020 May;62(5):633-639
pubmed: 31538331
Health Qual Life Outcomes. 2012 May 22;10:43
pubmed: 22545870
Neuromuscul Disord. 2016 Apr-May;26(4-5):264-71
pubmed: 27056113
Health Technol Assess. 2009 Feb;13(12):iii, ix-x, 1-177
pubmed: 19216837
Neurol Genet. 2016 Aug 04;2(4):e89
pubmed: 27602406
Continuum (Minneap Minn). 2019 Dec;25(6):1599-1618
pubmed: 31794462
PLoS One. 2018 Jun 20;13(6):e0199223
pubmed: 29924848
Neurology. 2019 Jan 09;:
pubmed: 30626655
Orphanet J Rare Dis. 2017 Nov 2;12(1):171
pubmed: 29096663
Neuromuscul Disord. 2009 Jan;19(1):21-5
pubmed: 19084402
Dev Med Child Neurol. 2013 Nov;55(11):1038-45
pubmed: 23902233
Continuum (Minneap Minn). 2016 Dec;22(6, Muscle and Neuromuscular Junction Disorders):1954-1977
pubmed: 27922502
Neurology. 2010 Jul 27;75(4):298-9
pubmed: 20574035

Auteurs

Anna G Mayhew (AG)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Meredith K James (MK)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Ursula Moore (U)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Helen Sutherland (H)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Marni Jacobs (M)

Center for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, United States.
Pediatrics, Epidemiology and Biostatistics, George Washington University, Washington, DC, United States.

Jia Feng (J)

Center for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, United States.

Linda Pax Lowes (LP)

The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.

Lindsay N Alfano (LN)

The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.

Robert Muni Lofra (R)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Laura E Rufibach (LE)

The Jain Foundation, Seattle, WA, United States.

Kristy Rose (K)

The Children's Hospital at Westmead, The University of Sydney, Sydney, NSW, Australia.

Tina Duong (T)

Cooperative International Neuromuscular Research Group (CINRG), Children's National Health System, Washington, DC, United States.
Lucile Salter Packard Children's Hospital at Stanford, Neurology, Palo Alto, CA, United States.

Luca Bello (L)

Department of Neuroscience, University of Padova, Padua, Italy.

Irene Pedrosa-Hernández (I)

Physical Medicine and Rehabilitation, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Scott Holsten (S)

Neuroscience Institute, Carolinas Neuromuscular/ALS-MDA Center, Carolinas HealthCare System, Charlotte, NC, United States.

Chikako Sakamoto (C)

Department of Physical Rehabilitation, National Center Hospital, National Center of Neurology and Psychiatry Tokyo, Tokyo, Japan.

Aurélie Canal (A)

Institut de Myologie, AP-HP, GH Pitié-Salpêtrière, Paris, France.

Nieves Sánchez-Aguilera Práxedes (N)

Neurorehabilitation Unit, Rehabilitation Hospital Universitario Virgen del Rocío Sevilla, Seville, Spain.

Simone Thiele (S)

Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.

Catherine Siener (C)

Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.

Bruno Vandevelde (B)

Service des Maladies Neuromusculaire et de la SLA, Hôpital de La Timone, Marseille, France.

Brittney DeWolf (B)

Cooperative International Neuromuscular Research Group (CINRG), Children's National Health System, Washington, DC, United States.

Elke Maron (E)

ELAN-PHYSIO, Praxis für Physiotherapie Maron, Berlin, Germany.

Heather Gordish-Dressman (H)

Center for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, United States.
Pediatrics, Epidemiology and Biostatistics, George Washington University, Washington, DC, United States.

Heather Hilsden (H)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Michela Guglieri (M)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Jean-Yves Hogrel (JY)

Institut de Myologie, AP-HP, GH Pitié-Salpêtrière, Paris, France.

Andrew M Blamire (AM)

Magnetic Resonance Centre, Institute for Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.

Pierre G Carlier (PG)

AIM & CEA NMR Laboratory, Institute of Myology, Pitié-Salpêtrière University Hospital, Paris, France.

Simone Spuler (S)

Charite Muscle Research Unit, Experimental and Clinical Research Center, A Joint Cooperation of the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine, Berlin, Germany.

John W Day (JW)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.

Kristi J Jones (KJ)

The Children's Hospital at Westmead, The University of Sydney, Sydney, NSW, Australia.

Diana X Bharucha-Goebel (DX)

Department of Neurology Children's National Health System, Washington, DC, United States.
National Institutes of Health (NINDS), Bethesda, MD, United States.

Emmanuelle Salort-Campana (E)

Service des Maladies Neuromusculaire et de la SLA, Hôpital de La Timone, Marseille, France.

Alan Pestronk (A)

Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.

Maggie C Walter (MC)

Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University of Munich, Munich, Germany.

Carmen Paradas (C)

Neuromuscular Unit, Department of Neurology, Hospital U. Virgen del Rocío/Instituto de Biomedicina de Sevilla, Sevilla, Spain.

Tanya Stojkovic (T)

Institut de Myologie, AP-HP, GH Pitié-Salpêtrière, Paris, France.

Madoka Mori-Yoshimura (M)

Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry Tokyo, Tokyo, Japan.

Elena Bravver (E)

Neuroscience Institute, Carolinas Neuromuscular/ALS-MDA Center, Carolinas HealthCare System, Charlotte, NC, United States.

Jordi Díaz-Manera (J)

Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Barcelona, Spain.
Neuromuscular Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Elena Pegoraro (E)

Department of Neuroscience, University of Padova, Padua, Italy.

Jerry R Mendell (JR)

The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.

Volker Straub (V)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Classifications MeSH